263 related articles for article (PubMed ID: 12720461)
1. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.
Bolskar RD; Benedetto AF; Husebo LO; Price RE; Jackson EF; Wallace S; Wilson LJ; Alford JM
J Am Chem Soc; 2003 May; 125(18):5471-8. PubMed ID: 12720461
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
[TBL] [Abstract][Full Text] [Related]
3. Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
Shu CY; Zhang EY; Xiang JF; Zhu CF; Wang CR; Pei XL; Han HB
J Phys Chem B; 2006 Aug; 110(31):15597-601. PubMed ID: 16884284
[TBL] [Abstract][Full Text] [Related]
4. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
5. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
6. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
8. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
9. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
10. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
11. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
12. High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.
Zhang J; Fatouros PP; Shu C; Reid J; Owens LS; Cai T; Gibson HW; Long GL; Corwin FD; Chen ZJ; Dorn HC
Bioconjug Chem; 2010 Apr; 21(4):610-5. PubMed ID: 20218678
[TBL] [Abstract][Full Text] [Related]
13. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
14. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents.
Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA
Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118
[TBL] [Abstract][Full Text] [Related]
15. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
16. (212)Pb@C(60) and its water-soluble derivatives: synthesis, stability, and suitability for radioimmunotherapy.
Diener MD; Alford JM; Kennel SJ; Mirzadeh S
J Am Chem Soc; 2007 Apr; 129(16):5131-8. PubMed ID: 17394315
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
18. Gd3N@C84(OH)x: a new egg-shaped metallofullerene magnetic resonance imaging contrast agent.
Zhang J; Ye Y; Chen Y; Pregot C; Li T; Balasubramaniam S; Hobart DB; Zhang Y; Wi S; Davis RM; Madsen LA; Morris JR; LaConte SM; Yee GT; Dorn HC
J Am Chem Soc; 2014 Feb; 136(6):2630-6. PubMed ID: 24432974
[TBL] [Abstract][Full Text] [Related]
19. A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging.
Hak S; Sanders HM; Agrawal P; Langereis S; Grüll H; Keizer HM; Arena F; Terreno E; Strijkers GJ; Nicolay K
Eur J Pharm Biopharm; 2009 Jun; 72(2):397-404. PubMed ID: 18940253
[TBL] [Abstract][Full Text] [Related]
20. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies.
Bertin A; Steibel J; Michou-Gallani AI; Gallani JL; Felder-Flesch D
Bioconjug Chem; 2009 Apr; 20(4):760-7. PubMed ID: 19368343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]